Guidance on evaluation fees for human drugs and disinfectants: Invoicing, fee payment and mitigation measures

Sponsors must complete the fee section of the Regulatory Enrolment Process (REP) Regulatory Transaction (RT) template. The RT template provides a link to the fees, and includes a section on fee mitigation measures.

Data and Resources

Additional Info

Field Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Lignes directrices sur les frais d’évaluation des médicaments à usage humain et des désinfectants assimilés à une drogue : Facturation, paiement des frais et mesures d’atténuation
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published 2023-02-08 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["présentations et demandes de médicaments", "présentation de médicaments pour humains et de désinfectants", "document d'orientation sur les frais", "frais d'examen", "frais d'évaluation", "facturation", "paiement des frais", "mesures d'atténuation"], "en": ["drug submissions-and-applications", "human-drugs-and-disinfectants submission", "guidance-document on fees", "fees for review", "evaluation fees", "invoicing", "fee payment", "mitigation measures"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source